Back to top

messenger-rna: Archive

Zacks Equity Research

Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine

The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change